Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (141-150 of 272) with videos related to

Pageof 28
Sort By:
International Journal of Oncology|October 9, 2002
Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomasAntonio D'Antonio, Simona Losito, Sandro Pignata, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Filippo de Marinis, Massimo Di Maio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
Journal of Personalized Medicine|April 3, 2021
Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic SyndromeCarles Perpiñan, Laia Bertran, Ximena Terra, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 7, 2025
Effect of immuno-oncology on clinical and economic outcomes for a selection of cancers in ItalyBeatrice Canali, Giovanni Apolone, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studiesCesare Gridelli, Paolo Maione, Alfonso Illiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Prognostic value of CD40 in adult soft tissue sarcomasAlessandro Ottaiano, Anna De Chiara, Francesco Perrone, et al.
Pageof 28

Showing results (141-150 of 272) with videos related to

Sort By:
Pageof 28
International Journal of Oncology|October 9, 2002
Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomasAntonio D'Antonio, Simona Losito, Sandro Pignata, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Filippo de Marinis, Massimo Di Maio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
Journal of Personalized Medicine|April 3, 2021
Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic SyndromeCarles Perpiñan, Laia Bertran, Ximena Terra, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 7, 2025
Effect of immuno-oncology on clinical and economic outcomes for a selection of cancers in ItalyBeatrice Canali, Giovanni Apolone, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studiesCesare Gridelli, Paolo Maione, Alfonso Illiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Prognostic value of CD40 in adult soft tissue sarcomasAlessandro Ottaiano, Anna De Chiara, Francesco Perrone, et al.
Pageof 28